Unlock instant, AI-driven research and patent intelligence for your innovation.

PEG-modified bifunctional anti-tumor recombinant protein conjugate based on folate receptor and macropinocytosis

A recombinant protein, folic acid receptor technology, applied in the field of biomedicine to achieve the effect of prolonging half-life and good application prospects

Active Publication Date: 2019-08-09
MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The preparation and application of a class of antineoplastic drugs based on folic acid receptor and macropinocytosis described in the present invention have not been reported at home and abroad so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PEG-modified bifunctional anti-tumor recombinant protein conjugate based on folate receptor and macropinocytosis
  • PEG-modified bifunctional anti-tumor recombinant protein conjugate based on folate receptor and macropinocytosis
  • PEG-modified bifunctional anti-tumor recombinant protein conjugate based on folate receptor and macropinocytosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1, expression and purification of recombinant protein HSA-LDP in Pichia pastoris

[0065] Inoculate the engineering strain expressing the recombinant protein HSA-LDP (sent to the General Microorganism Center of China Microbiological Culture Collection Management Committee for preservation, preservation number CGMCC No.17450) in BMGY growth medium (10% yeast extract, 20% peptone, 1.34 %YNB, 4×10-5% biotin, 100mM pH 6.0 potassium phosphate buffer, 10% glycerol), 220rpm, cultured at 30°C for 36h, left standing at room temperature or centrifuged to collect the bacteria, and transferred to BMMY induction medium (10% yeast extract, 20% peptone, 1.34% YNB, 4 × 10-5% biotin, 100mM pH 6.0 potassium phosphate buffer, 10% methanol), 250rpm, 28°C for 73h (add 100 % methanol to a final concentration of 1%). The recombinant protein was secreted and expressed in the supernatant of the culture medium, and the supernatant was collected by centrifugation, filtered through a 0...

Embodiment 2

[0066] Example 2, Preparation and Purification of Recombinant Protein Conjugate F-HSA-LDP

[0067] 1. Preparation of recombinant protein conjugate F-HSA-LDP

[0068] figure 1 -A is a flow chart for the construction of recombinant protein conjugate F-HSA-LDP and enhanced F-HSA-LDP-AE. Folic acid-PEG propionaldehyde (molecular weight 10KDa, purity>95%) was purchased from Shanghai Pengshuo Biotechnology Co., Ltd., sodium cyanoborohydride (CH 3 BrNa) was purchased from Sigma Company. Prepare the purified HSA-LDP protein with pH6.0, 10mmol / L sodium acetate solution to make 5mg / ml, weigh 0.0126g CH 3 BrNa was added to 10ml of the above HSA-LDP solution to a final concentration of 20mmol / L, and 0.038g of folic acid-PEG was weighed at a molar ratio of 1:5 (HSA-LDP: folic acid-PEG) and added to the above solution. Min stirring reaction 24h.

[0069] 2. Purification of recombinant protein conjugate F-HSA-LDP

[0070] The reaction mixture was first dialyzed against 20mM Tris-HCl bu...

Embodiment 3

[0071] Example 3. Analysis of affinity activity between recombinant protein conjugate F-HSA-LDP and FR protein and tumor cells 1. ELISA detection of affinity activity of recombinant protein conjugate F-HSA-LDP on FR protein and pancreatic cancer cells

[0072] ELISA folic acid receptor detection kit was purchased from Wuhan Huamei Biological Company. Pancreatic cancer cells BxPc-3, MIAPaCa-2 and AsPc-1 were treated with 1×10 4 Cells / well density were seeded in a 96-well plate, cultured at 37°C for 24 hours, rinsed twice with PBS, added 50 μl / well of pre-cooled 0.05% glutaraldehyde at 4°C, fixed the cells at 4°C for 20 minutes, and fixed the cells Rinse with PBS 3 times, dry the residual liquid and set aside. The 96-well plate pre-coated with folic acid receptors and the 96-well plate after cell fixation were blocked with 5% skim milk solution at 200 μl / well at room temperature for 2 h; moistened with PBST buffer (0.05% Tween-20 in PBS) Wash 3 times; dilute the recombinant pr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Volumeaaaaaaaaaa
Ionic strengthaaaaaaaaaa
Login to View More

Abstract

The invention discloses a PEG-modified bifunctional anti-tumor recombinant protein conjugate based on a folate receptor and macropinocytosis and a preparation method and application of the conjugate.The recombinant protein conjugate is named F-HSA-LDP and is composed of folic acid-PEG, human serum albumin and a Lida-protein LDP of lidamycin and formed through a reaction between an aldehyde groupof the folic acid-PEG and an N-terminal amino group of a recombinant protein HSA-LDP. The novel recombinant protein conjugate F-HSA-LDP can target the folate receptor, has the strong activity of killing tumor cells, has a longer half-life period compared with HSA-LDP, and is expected to be developed into a novel anti-tumor drug.

Description

[0001] Technical field: [0002] The invention belongs to the field of biomedicine, and relates to the preparation and application of a kind of PEG-modified bifunctional anti-tumor recombinant protein conjugate based on folic acid receptor and macropinocytosis. [0003] Background technique: [0004] The folate receptor (FR)-mediated targeted drug delivery system uses the difference in the expression of folate receptors on the surface of tumor cells and normal cells to specifically bind to folate receptors highly expressed on the surface of tumor cells to achieve folic acid binding. targeted delivery of substances. The folate receptor is a membrane glycoprotein linked by glycosyl phosphatidylinositol (GPI), with a molecular weight of 38-40kDa, which can mediate endocytosis and take folic acid into the cytoplasm of eukaryotic cells a high-affinity receptor. Folate receptors are highly expressed on the surface of some tumor cells, but not or rarely expressed in normal tissues, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K47/64A61K47/60A61K47/54A61K47/65A61K38/16A61P35/00
CPCA61K47/643A61K47/60A61K47/545A61K47/65A61K38/16A61P35/00
Inventor 王阳阳刘秀均李良甄永苏李毅
Owner MEDICINE & BIOENG INST OF CHINESE ACAD OF MEDICAL SCI